Johnson & Johnson
JNJJohnson & Johnson (JNJ) is a Healthcare company that currently yields 2.06% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $153.90 and the overvaluation threshold at $194.08. Johnson & Johnson holds a quality score of 47/100 (Average), reflecting 64 consecutive years of dividend growth with a 60% payout ratio. The 5-year dividend CAGR stands at 5.2%.
JNJ Dividend Yield History — Weiss Valuation
Distance to undervalued
Entry price is stretched
Needs 39.6% downside to reach the Weiss buy zone
Undervaluation starts near $153.90, where the annual dividend would imply roughly 3.40% yield. That is 1.35% above today's yield.
Buy-zone price
$153.90
Target yield
3.40%
Research checklist
What to clear before buying the yield
Updated Jun 29, 2026
Dividend durability
64YLong dividend history supports a deeper look.
Earnings payout
60%Earnings coverage leaves room for noise.
Cash payout
103%Confirm cash conversion and one-off effects.
Dividend growth
5.2%Recent growth adds income compounding potential.
What changed
What changed since the last update
2026-06-28 → 2026-06-29
No major change in signal, yield, price, quality, or payout since the last update.
Why Now?
Johnson & Johnson is trading near its historical overvaluation band.
Current yield 2.1% vs historical max 4.9% (42% of maximum).
14 consecutive years without a dividend cut.
Reasonable payout ratio of 60%.
What matters now
Read the signal before the headline yield
Valuation is the brake here: the yield is compressed versus its own history.
The 47/100 quality score says the headline yield needs extra skepticism.
Free cash flow payout is above 100%, so cash coverage is the first risk to unpack.
JNJ Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$216
Year 10 Income
$433
Yield on Cost
4.48%
Total Income
$3,113
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
Track actual vs. projected
See what JNJ dividends you actually received with Sharesight
Dividend income log · Yield on cost · DRIP cost basis · Tax reports
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗Track dividends received & tax reports
Sharesight ↗JNJ Dividend Quality Score
Quality Score
Average
Key Metrics
Invest in JNJ
Buy Johnson & Johnson commission-free on eToro
Start investing on eToro →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ JNJ Dividend Analysis ArticleRelated Reading
Collections